Latest news

Insights

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

Executive Summary Artificial intelligence is beginning to reshape competitive dynamics across the pharmaceutical and biotechnology industry. For decades, large pharmaceutical companies...
Insights

The AI Talent War in Life Sciences Is Just Beginning

AI Talent:Executive Summary Artificial intelligence is no longer a tooling upgrade in life sciences—it is becoming a labor constraint problem...
Clinical

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

Eli Lilly said its experimental obesity drug retatrutide met the primary endpoint in the phase 3 TRIUMPH-1 study, helping...
Clinical

BioMarin Reports Phase 3 Growth Improvements for Voxzogo in Hypochondroplasia

BioMarin has reported phase 3 results for its dwarfism drug Voxzogo in children with hypochondroplasia (HChttps://lifescivoice.com/H), a rare genetic...
Insights

Synthetic Data in Healthcare: The Next Frontier or a Compliance Risk?

Executive Summary Synthetic data is rapidly emerging as one of...
Clinical

Immunovant Forced to Pay Out to Scrap FcRn Inhibitor Following Phase 3 Failure

Immunovant has announced that it has discontinued development of...
Clinical

Parabilis Plans Phase 3 Trial of Zolucatetide for Desmoid Tumors

Parabilis Medicines is preparing to advance the development of zolucatetide, its Wnt/β-catenin pathway inhibitor, with plans to launch a...
Commercial

Incyte Expands Genesis AI Drug Discovery Partnership in Deal Worth Over $1 Billion

Incyte and Genesis Molecular AI have expanded their collaboration focused on applying artificial intelligence to drug discovery, with the...
Clinical

BioMarin’s BMN 401 Meets One Primary Goal but Misses Clinical Endpoint in Late-Stage ENPP1 Deficiency Trial

BioMarin Pharmaceutical said its experimental enzyme replacement therapy BMN 401 met one of two primary goals in a late-stage...
Regulatory

AstraZeneca receives approval for blood pressure medication

AstraZeneca's baxdrostat is approved by the FDA to treat...
Clinical

Regeneron’s Melanoma Drug Underperforms in Phase 3 Trial

A phase 3 study of Regeneron Pharmaceuticals’ LAG-3 inhibitor...
Insights

Will AI Replace Traditional CRO Models in Clinical Research?

Executive Summary Artificial intelligence is reshaping clinical research, but it is not simply replacing existing operational models—it is redistributing how...
Insights

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

Executive Summary Life sciences organizations are entering a new era where competitive advantage is increasingly defined not only by scientific...
Regulatory

Following FDA hold, Aardvark will examine phase 3 data early

Aardvark Therapeutics is set to disclose results from its phase 3 Prader-Willi syndrome (PWS) development program following the FDA's...
Regulatory

AstraZeneca receives approval for blood pressure medication

AstraZeneca's baxdrostat is approved by the FDA to treat...
Editorial Team -
Commercial

Incyte Expands Genesis AI Drug Discovery Partnership in Deal Worth Over $1 Billion

Incyte and Genesis Molecular AI have expanded their collaboration...
Editorial Team -
Commercial

Pentixapharm Acquires Glycotope for its target discovery business

In a bid to amp up its radiopharmaceuticals pipeline,...
Commercial

Disco Pharmaceuticals Unveils Surfaceome Mapping for Enhanced Cancer Therapeutics

Disco Pharmaceuticals has recently taken the pharmaceutical stage, bolstered...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

AstraZeneca receives approval for blood pressure medication

AstraZeneca's baxdrostat is approved by the FDA to treat...
Editorial Team -
Insights

The AI Talent War in Life Sciences Is Just Beginning

AI Talent:Executive Summary Artificial intelligence is no longer a tooling...
Clinical

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

Eli Lilly said its experimental obesity drug retatrutide met...
Clinical

BioMarin Reports Phase 3 Growth Improvements for Voxzogo in Hypochondroplasia

BioMarin has reported phase 3 results for its dwarfism...
Insights

What Makes Life Sciences Data “AI-Ready”?

Executive Summary Artificial intelligence is rapidly becoming embedded across life...

Research & Development

Market Access

Manufacturing

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

Cellares has raised $257 million in a Series D...
Manufacturing

Recipharm Commissions Bengaluru Facility for Nonbacterial Beta-Lactam Tablet Manufacturing

Swedish contract development and manufacturing organization (CDMO) Recipharm has...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

Executive Summary Artificial intelligence is beginning to reshape competitive dynamics...
Editorial Team -
Clinical

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

Eli Lilly said its experimental obesity drug retatrutide met...
Editorial Team -